İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bausch health ireland limited - phenylephrine hydrochloride - eye drops, solution - 2.5 percent weight/volume - sympathomimetics used as decongestants; phenylephrine

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

bausch + lomb ireland limited - phenylephrine hydrochloride - eye drops, solution - sympathomimetics used as decongestants; phenylephrine

Kanada - İngilizce - Health Canada

sandoz canada incorporated - phenylephrine (phenylephrine hydrochloride) - liquid - 10mg - phenylephrine (phenylephrine hydrochloride) 10mg - alpha-adrenergic agonists

Kanada - İngilizce - Health Canada

marcan pharmaceuticals inc - phenylephrine hydrochloride - solution - 10mg - phenylephrine hydrochloride 10mg - alpha-adrenergic agonists

Kanada - İngilizce - Health Canada

sterimax inc - phenylephrine hydrochloride - solution - 10mg - phenylephrine hydrochloride 10mg - vasoconstrictors

Malta - İngilizce - Medicines Authority

laboratoire aguettant 1 rue alexander fleming, 69007 lyon, france - phenylephrine hydrochloride - solution for injection in a pre-filled syringe - phenylephrine hydrochloride 50 µg/ml - cardiac therapy

Kanada - İngilizce - Health Canada

laboratoire aguettant - phenylephrine hydrochloride - solution - 50mcg - phenylephrine hydrochloride 50mcg - alpha-adrenergic agonists

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - phenylephrine hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; citric acid monohydrate; sodium citrate dihydrate; sodium metabisulfite; water for injections; sodium chloride - for the maintenance of an adequate level of blood pressure during spinal and inhalation anaesthesia and for the treatment of vascular failure in shock, shock-like states, and drug-induced hypotension, or hypersensitivity. it is also employed to overcome paroxysmal supraventricular tachycardia, to prolong spinal anaesthesia, and as a vasoconstrictor in regional analgesia

ABD - İngilizce - NLM (National Library of Medicine)

physicians total care, inc. - codeine phosphate (unii: gsl05y1mn6) (codeine - unii:q830pw7520), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - codeine phosphate 10 mg in 5 ml - promethazine hcl, phenylephrine hcl and codeine phosphate syrup is indicated for the temporary relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. codeine is contraindicated in patients with a known hypersensitivity to the drug. promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. the combination of promethazine hydrochloride, phenylephrine hydrochloride and codeine phosphate is contraindicated in pediatric patients less than 6 years of age, because the combination may cause fatal respiratory depression in this age population. antihistamines and codeine are both contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. phenylephrine is contraindicated in patients with hypertension or with peripheral vascular insufficiency (ischemia may result with risk of gangrene or thrombosi

ABD - İngilizce - NLM (National Library of Medicine)

dispensing solutions, inc. - codeine phosphate (unii: gsl05y1mn6) (codeine - unii:q830pw7520), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - codeine phosphate 10 mg in 5 ml - promethazine hcl, phenylephrine hcl and codeine phosphate syrup is indicated for the temporary relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. codeine is contraindicated in patients with a known hypersensitivity to the drug. promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. the combination of promethazine hydrochloride, phenylephrine hydrochloride and codeine phosphate is contraindicated in pediatric patients less than 6 years of age, because the combination may cause fatal respiratory depression in this age population. antihistamines and codeine are both contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. phenylephrine is contraindicated in patients with hypertension or with peripheral vascular insufficiency (ischemia may result with risk of gangrene or thrombosi